Home » Topics » BioWorld Science

BioWorld Science
RSS

N-803 plus BCG shows promise for treating NMIBC

Feb. 18, 2021

Highly phosphorylated GCase M-011 exhibits improved potential in Gaucher disease

Feb. 18, 2021

First patient dosed in phase I study of IkT-148009

Feb. 18, 2021

New anoctamin-1 potentiators synthesized at Enterprise Therapeutics

Feb. 18, 2021

Sichuan Haisco Pharmaceutical identifies kappa-opioid receptor agonist derivatives

Feb. 18, 2021

University of Texas, Axxam patent CX3CR1 and/or CX3CL1 agonists

Feb. 18, 2021

AstraZeneca discovers arginase-1 and arginase-2 inhibitors

Feb. 18, 2021

New ENPP2 inhibitors identified at Boehringer Ingelheim

Feb. 18, 2021

Topline data from phase Ib study of AMG-0103 in chronic discogenic low back pain

Feb. 18, 2021

Nektar announces new collaborations for registrational study of bempegaldesleukin in SCCHN

Feb. 18, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 16, 2025.
Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA
BioWorld
During a conference call after the U.S. FDA approval of Zusduri (mitomycin), Urogen Pharma Ltd. CEO Liz Barrett offered candid observations about a...
23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...